PRMT1 suppresses doxorubicin-induced cardiotoxicity by inhibiting endoplasmic reticulum stress
- 18 July 2022
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 98, 110412
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, ICT and Future Planning (NRF-2021R1I1A1A01050302, NRF-2022R1A2B5B02001482)
- National Research Foundation of Korea
This publication has 36 references indexed in Scilit:
- Doxorubicin CardiomyopathyCardiology, 2009
- A Mouse PRMT1 Null Allele Defines an Essential Role for Arginine Methylation in Genome Maintenance and Cell ProliferationMolecular and Cellular Biology, 2009
- Epigenetic Regulation of Transcriptional Activity of Pregnane X Receptor by Protein Arginine Methyltransferase 1Journal of Biological Chemistry, 2009
- Human protein arginine methyltransferases in vivo – distinct properties of eight canonical members of the PRMT familyJournal of Cell Science, 2009
- The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growthCancer Biology & Therapy, 2006
- Arginine MethylationMolecular Cell, 2005
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Protein arginine methyltransferase I: Substrate specificity and role in hnRNP assemblyJournal of Cellular Biochemistry, 2002
- PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian CellsJournal of Biological Chemistry, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999